2024-04-30 2025-04-30 false Capium Accounts Production 1.1 15694814 2024-04-30 2025-04-30 15694814 bus:FullAccounts 2024-04-30 2025-04-30 15694814 bus:FRS102 2024-04-30 2025-04-30 15694814 bus:AuditExemptWithAccountantsReport 2024-04-30 2025-04-30 15694814 bus:SmallCompaniesRegimeForAccounts 2024-04-30 2025-04-30 15694814 bus:PrivateLimitedCompanyLtd 2024-04-30 2025-04-30 15694814 2024-04-30 2025-04-30 15694814 2025-04-30 15694814 bus:RegisteredOffice 2024-04-30 2025-04-30 15694814 core:WithinOneYear 2025-04-30 15694814 core:AfterOneYear 2025-04-30 15694814 1 2024-04-30 2025-04-30 15694814 bus:Director1 2024-04-30 2025-04-30 15694814 bus:Director1 2025-04-30 15694814 2023-04-30 15694814 bus:LeadAgentIfApplicable 2024-04-30 2025-04-30 15694814 2024-04-29 15694814 bus:OrdinaryShareClass1 2024-04-30 2025-04-30 15694814 bus:OrdinaryShareClass1 2025-04-30 15694814 core:CostValuation core:Non-currentFinancialInstruments 2025-04-30 15694814 core:CostValuation core:Non-currentFinancialInstruments 2024-04-29 15694814 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-04-30 15694814 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-04-30 15694814 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-04-30 15694814 core:Non-currentFinancialInstruments 2025-04-30 15694814 core:Non-currentFinancialInstruments 2024-04-29 15694814 core:ShareCapital 2025-04-30 15694814 core:RetainedEarningsAccumulatedLosses 2025-04-30 15694814 core:ShareCapitalOrdinaryShares 2024-04-30 15694814 core:ShareCapitalOrdinaryShares 2024-04-30 2025-04-30 15694814 core:ShareCapitalOrdinaryShares 2025-04-30 15694814 core:RevaluationReserve 2024-04-30 15694814 core:RevaluationReserve 2024-04-30 2025-04-30 15694814 core:RevaluationReserve 2025-04-30 15694814 core:CapitalRedemptionReserve 2024-04-30 15694814 core:CapitalRedemptionReserve 2024-04-30 2025-04-30 15694814 core:CapitalRedemptionReserve 2025-04-30 15694814 core:RetainedEarningsAccumulatedLosses 2024-04-30 15694814 core:RetainedEarningsAccumulatedLosses 2024-04-30 2025-04-30 15694814 core:RetainedEarningsAccumulatedLosses 2025-04-30 15694814 dpl:Item1 2024-04-30 15694814 dpl:Item1 2025-04-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 15694814
England and Wales

 

 

 

DALDERMA LTD



Unaudited Financial Statements
 


Period of accounts

Start date: 30 April 2024

End date: 30 April 2025
Director Dalvir Singh BAJWA
Registered Number 15694814
Registered Office 71-75 Shelton Street, Covent Garden
London
WC2H 9JQ
Accountants Acumen Accounting
364 West Road
Newcastle Upon Tyne
Tyne & Wear
NE4 9JY
1
Director's report and financial statements
The director presents his/her/their annual report and the financial statements for the year ended 30 April 2025.
Principal activities
Principal activity of the company during the financial period 30 April 2025 was of Other professional, scientific and technical activities not elsewhere classified and Specialists medical practice activities
Director
The director who served the company throughout the year was as follows:
Dalvir Singh BAJWA
Statement of director's responsibilities
The director is responsible for preparing the directors' report and the financial statements in accordance with applicable law and regulations and in accordance with United Kingdom Generally Accepted Accounting Practice.
Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the director must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the profit or loss of the company for that period.

In preparing these financial statements, the director is required to :
  • select suitable accounting policies and then apply them consistently
  • make judgements and accounting estimates that are reasonable and prudent
  • state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements and
  • prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The director is responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. The director is also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

The director is responsible for the maintenance and integrity of the corporate and financial information included on the company's website. Legislation in the United Kingdom, governing the preparation and dissemination of financial statements, may differ from legislation in other jurisdictions

On behalf of the board.


----------------------------------
Dalvir Singh BAJWA
Director

Date approved: 05 August 2025
2
Accountant’s report
You consider that the company is exempt from an audit for the year ended 30 April 2025 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year.
In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us.
We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts.
Acumen Accounting
30 April 2025



....................................................
Acumen Accounting
364 West Road
Newcastle Upon Tyne
Tyne & Wear
NE4 9JY
05 August 2025
3
 
 
Notes
 
2025
£
Turnover 97,820 
Cost of sales (1,283)
Gross profit 96,537 
Administrative expenses (34,152)
Operating profit 62,385 
Profit/(Loss) on ordinary activities before taxation 62,385 
Tax on profit on ordinary activities (12,772)
Profit/(Loss) for the financial year 49,613 
 
4
 
 
Notes
 
2025
£
Current assets    
Cash at bank and in hand 20,083 
Creditors: amount falling due within one year 3 (14,512)
Net current assets 5,571 
 
Total assets less current liabilities 5,571 
Net assets 5,571 
 

Capital and reserves
   
Called up share capital 4 1 
Profit and loss account 5,570 
Shareholders' funds 5,571 
 


For the year ended 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the director on 05 August 2025 and were signed by:


-------------------------------
Dalvir Singh BAJWA
Director
5
  Equity share capital   Revaluation reserve   Capital redemption reserve   Retained Earnings   Total
£ £ £ £ £
At 30 April 2024
Profit for the year 49,613  49,613 
Total comprehensive income for the year 49,613  49,613 
Dividends (44,043) (44,043)
Shares issued 1 
Total investments by and distributions to owners 1  (44,043) (44,042)
At 30 April 2025 1  5,570  5,571 
6
General Information
DALDERMA LTD is a private company, limited by shares, registered in England and Wales, registration number 15694814, registration address 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
2.

Average number of employees

Average number of employees during the year was 0.
3.

Creditors: amount falling due within one year

2025
£
Corporation Tax 12,772 
Accrued Expenses 1,740 
14,512 

4.

Share Capital

Allotted, called up and fully paid
2025
£
1 Class A share of £1.00 each

7